These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30327774)

  • 1. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
    Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
    Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
    Li LY; Jiang H; Xie YM; Liao LD; Cao HH; Xu XE; Chen B; Zeng FM; Zhang YL; Du ZP; Chen H; Huang W; Jia W; Zheng W; Xie JJ; Li EM; Xu LY
    Oncotarget; 2015 Jun; 6(18):15940-52. PubMed ID: 25909284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
    Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
    Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics reveals the downregulation of GRB2 as a prominent node of F806-targeted cell proliferation network.
    Li LY; Zhang K; Jiang H; Xie YM; Liao LD; Chen B; Du ZP; Zhang PX; Chen H; Huang W; Jia W; Cao HH; Zheng W; Li EM; Xu LY
    J Proteomics; 2015 Mar; 117():145-55. PubMed ID: 25659534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
    Liang F; Wang YG; Wang C
    Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis.
    Li M; Wang L; Zhan Y; Zeng T; Zhang X; Guan XY; Li Y
    Am J Pathol; 2019 Jul; 189(7):1462-1472. PubMed ID: 31054987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.
    Niu G; Zhuang H; Li B; Cao G
    J BUON; 2018; 23(1):157-162. PubMed ID: 29552776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
    Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
    Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.
    Xiang G; Yi Y; Weiwei H; Weiming W
    Tumour Biol; 2016 Jan; 37(1):773-9. PubMed ID: 26250459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
    Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
    Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
    Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM
    Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
    Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
    Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
    Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S
    J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
    Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
    Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
    Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor.
    Wang H; Wang Y; Liang B; He F; Li Y; Che J; Li X; Zhao H; Shi G
    J Cancer Res Ther; 2016 Oct; 12(Supplement):60-63. PubMed ID: 27721256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.